# Ribociclib

## Kisqali 200mg

| TAH Drug Code      | [OKIS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OKIS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | KISQALI is indicated for: - In combination with aromatase inhibitors， as initial endocrine treatment for hormone receptor (HR)-positive， HER2-negative， locally advanced or metastatic breast cancer in men or premenopausal， perimenopausal， or postmenopausal women; or - In combination with fulvestrant， as initial endocrine treatment or after disease progression during endocrine therapy for hormone receptor (HR)-positive， HER2-negative， locally advanced or metastatic breast cancer in men or postmenopausal women.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | 600 mg orally once daily for 21 consecutive days followed by 7 days off treatment resulting in a complete cycle of 28 days. KISQALI can be taken with or without food. Coadminister KISQALI with letrozole 2.5 mg taken once daily throughout the 28-day cycle. Patients should take their dose of KISQALI and letrozole at approximately the same time each day， preferably in themorning.  Recommended Dose Modification for Adverse Reactions: - Starting dose: 600 mg/day (three 200 mg tablets) - 1st dose reduction: 400 mg/day (two 200 mg tablets) - 2nd dose reduction: 200 mg/day (one 200 mg tablet) If further dose reduction below 200 mg/day is required， discontinue the treatment.                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Known hypersensitivity to Ribociclib succinate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | >10%: Cardiovascular: Peripheral edema (12%) Central nervous system: Fatigue (37%)， headache (22%)， insomnia (12%) Dermatologic: Alopecia (33%)， skin rash (17%)， pruritus (14%) Endocrine & metabolic: Decreased serum potassium (11%) Gastrointestinal: Nausea (52%)， diarrhea (35%)， vomiting (29%)， constipation (25%)， decreased appetite (19%)， stomatitis (12%)， abdominal pain (11%) Genitourinary: Urinary tract infection (11%) Hematologic & oncologic: Neutropenia (75%; grade 3: 50%; grade 4: 10%)， leukopenia (33%; grade 3: 20%; grade 4: 1%)， decreased platelet count (29%; grade 3: 1%)， anemia (18%; grade 4: <1%)， abnormal phosphorus levels (decreased; 13%; grade 3: 5%; grade 4: 1%)， lymphocytopenia (11%; grade 3: 6%; grade 4: 1%) Hepatic: Increased serum ALT (<46%)， increased serum AST (<44%)， increased serum bilirubin (18%) Neuromuscular & skeletal: Back pain (20%) Renal: Increased serum creatinine (20%) Respiratory: Dyspnea (12%) Miscellaneous: Fever (13%) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ribociclib-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

